Career Investors Lilly in Europe Contact A. A. A. about us responsibility Products research PRODUCTS OUR PRODUCTS HELP PEOPLE ALL OVER THE WORLD Eli Lilly and Company is one of the world's leading pharmaceutical companies, committed to research and innovation. The company's core areas are endocrinology (diabetes, osteoporosis), oncology, psychiatry / neurology, urology, cardiology and autoimmune diseases. In its own research centers and in collaboration with international research organizations, Lilly develops new treatment approaches and technologies that help improve the health and quality of life of patients. Dermatology Taltz ® (ixekizumab) Diabetes Abasaglar ® (Insulin Glargine) Humalog ® (Insulin Lispro) Humulin ® (Insulin Human) Trulicity ® (Dulaglutide) Humapen ® Luxura HD Humapen ® Savvio ™ Cardiovascular diseases Adcirca ® (Tadalafil) * ReoPro ® (Abciximab) ** Oncology Alimta ® (Pemetrexed) Cyramza ® (Ramucirumab) Gemzar ® (Gemcitabine) Portrazza ® (Necitumumab) Osteoporosis Forsteo ® (Teriparatide) Psychiatry / Neurology Cymbalta ® (Duloxetine) Strattera ® (Atomoxetine) Zyprexa ® (Olanzapine) Zypadhera ® (Olanzapine Pamoat) Fluctine ® (Fluoxetine) Urology Cialis ® (Tadalafil) Yentreve ® (Duloxetine) Growth disorders Humatrope ® (Somatropin) * Lilly is the marketing authorization holder but is not involved in the promotion of the product ** Lilly is not the marketing authorization holder but is involved in the promotion or marketing or distribution of the product COUNTERFEIT DRUGS ANTI-COUNTERFEITING INITIATIVES imprint terms of use privacy sitemap Copyright © 2014 Eli Lilly GmbH. All rights reserved ATLLG00023 June 2016 Last change: 20/06/16 07:40:13